TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Delveinsight
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight

The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is expected to grow significantly between 2025-2034, driven by rising cancer incidence, lack of approved therapies, and emerging novel drug treatments.

Insights
NVDA   neutral

Mentioned as a collaboration partner for autonomous driving technology, no direct financial impact discussed


DWTX   positive

Enrolled first 50 patients in Phase IIb clinical trial for CIPN treatment, indicating active research and development progress